Oniria Therapeutics
PrivateLast Round
Grant
Dec 16, 2025
Total Funding Raised
$5.69M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Oniria Therapeutics is a biotechnology company that develops precision oncology therapies designed to counteract cancer resistance and combat disease relapse.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oniria Therapeutics Comparables
Compare Oniria Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hemispherian AS | 83% | |
| HiberCell | 75% | |
| Otsuka Holdings | 61% | |
Oniria Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 16, 2025 | ||||
| Grant | May 8, 2025 | ||||
| Seed | May 11, 2023 |
Key People
Founding team and executive leadership
Oniria Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union | Grant |
| BStartup Banco Sabadell | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 16, 2025
$2M raised from the European Union.
- Jun 1, 2025
Monthly visitors grew 65% MoM, reaching 1.3K.
Oniria Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oniria Therapeutics's valuation, stock price, and market status.